Targeting HER2 in Esophageal CancerTargeting HER2 in Esophageal Cancer
Human epidermal growth factor antagonists are being tested in HER2-positive gastric and gastroesophageal junction tumors. Cancer Control: Journal of the Moffitt Cancer Center
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Hematology-Oncology Journal Article Source Type: news
More News: Cancer | Cancer & Oncology | Esophagus Cancer | Gastric (Stomach) Cancer | Gastroenterology | Health | Hematology | HER2